Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 990,132 $ 1,201,112
Restricted cash 827,545 503,397
Accounts and other receivables 154,167 5,749
Inventory 63,853 18,125
Other current assets 69,030 54,203
Total current assets 2,104,727 1,782,586
Non-current restricted cash 31,128 31,722
Property, plant and equipment, net 19,891,666 16,193,907
Debt issuance costs, net 294,059 378,677
Non-current derivative assets 11,247 30,887
Goodwill 76,819 76,819
Other non-current assets 279,434 314,455
Total assets 22,689,080 18,809,053
Current liabilities    
Accounts payable 38,569 22,820
Accrued liabilities 699,996 427,199
Current debt, net 1,781,511 1,673,379
Deferred revenue 26,709 26,669
Derivative liabilities 61,829 35,201
Other current liabilities 264 0
Total current liabilities 2,608,878 2,185,268
Long-term debt, net 19,033,513 14,920,427
Non-current deferred revenue 6,500 9,500
Non-current derivative liabilities 268,601 79,387
Other non-current liabilities 65,849 53,068
Commitments and contingencies (see Note 16)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at September 30, 2016 and December 31, 2015; Issued and outstanding: 235.1 million shares and 235.6 million shares at September 30, 2016 and December 31, 2015, respectively 705 708
Treasury stock: 12.1 million shares and 11.6 million shares at September 30, 2016 and December 31, 2015, respectively, at cost (372,531) (353,927)
Additional paid-in-capital 3,112,753 3,075,317
Accumulated deficit (4,343,646) (3,623,948)
Total stockholders’ deficit (1,602,719) (901,850)
Non-controlling interest 2,308,458 2,463,253
Total equity 705,739 1,561,403
Total liabilities and equity $ 22,689,080 $ 18,809,053